Literature DB >> 23623644

Corticosteroid therapy for cardiac sarcoidosis: a systematic review.

Mouhannad M Sadek1, Derek Yung, David H Birnie, Rob S Beanlands, Pablo B Nery.   

Abstract

BACKGROUND: There are no published clinical consensus guidelines or systematic evaluation supporting the use of corticosteroids for the treatment of cardiac sarcoidosis. The purpose of this study was to systematically review the published data on corticosteroid treatment of cardiac sarcoidosis.
METHODS: Studies were identified from MEDLINE, EMBASE, Cochrane Controlled Trials Register, Cochrane Database of Systematic Reviews, and National Institutes of Health Clinical Trials.gov database. The quality of included articles was rated using Scottish Intercollegiate Guidelines Network 50. Outcomes examined were atrioventricular (AV) conduction, left ventricular function, ventricular arrhythmias, and mortality.
RESULTS: A total of 1491 references were retrieved and 10 publications met the inclusion criteria. There were no randomized trials and all publications were of poor to fair quality. In the 10 reports, 257 patients received corticosteroids and 42 patients did not. There were 57 patients with AV conduction disease treated with corticosteroids, with 27/57 (47.4%) improving. In contrast, 16 patients were not treated with corticosteroids and 0/16 improved. Four publications reported on left ventricular function recovery, 2 reported on ventricular arrhythmia burden, and 9 reported on mortality. However, the data quality were too limited to draw conclusions for any of these outcomes.
CONCLUSIONS: Our systematic review identified 10 publications reporting outcomes after corticosteroid therapy. The best data relates to AV conduction recovery and corticosteroids appeared to be beneficial. It is not possible to draw clear conclusions about the utility of corticosteroids for the other outcomes. There is a clear need for large multicentre prospective registries and trials in this patient population.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623644     DOI: 10.1016/j.cjca.2013.02.004

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  57 in total

Review 1.  Cardiac Sarcoidosis.

Authors:  Pranav Mankad; Brian Mitchell; David Birnie; Jordana Kron
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

Review 2.  Arrhythmias in structural heart disease.

Authors:  H Sawyer Gillespie; Charles C H Lin; Jordan M Prutkin
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

Review 4.  Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines.

Authors:  Dae-Won Sohn; Jun-Bean Park; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim
Journal:  Clin Cardiol       Date:  2018-10-17       Impact factor: 2.882

Review 5.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

6.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

Review 7.  Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis.

Authors:  Ibtisam Ashraf; Mercedes Maria Peck; Ruchira Maram; Alaa Mohamed; Diego Ochoa Crespo; Gurleen Kaur; Bilal Haider Malik
Journal:  Cureus       Date:  2020-08-18

8.  Isolated Cardiac Sarcoidosis Presenting with Stroke.

Authors:  Masanari Kuwabara; Rieko Niitsu Ishimura; Sugao Ishiwata; Minoru Ohno
Journal:  Korean Circ J       Date:  2018-03       Impact factor: 3.243

9.  The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Sumeet Pawar; Praveen Govender; Jeffrey Berman; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

10.  Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction.

Authors:  Gillian Murtagh; Luke J Laffin; Kershaw V Patel; Amit V Patel; Catherine A Bonham; Zoe Yu; Karima Addetia; Nadia El-Hangouche; Francesco Maffesanti; Victor Mor-Avi; D Kyle Hogarth; Nadera J Sweiss; John F Beshai; Roberto M Lang; Amit R Patel
Journal:  Echocardiography       Date:  2016-09       Impact factor: 1.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.